Definitive Contract 75F40123C00144
- Not listed
- This is a $301,014.00 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The contract supports a precedent-based approach to decision-making and the development of a maturity model for pharmaceutical quality system assessment. This award is a sole source contract set aside for 8(a) companies. Caitta Inc. specializes in providing...
- This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB). The contract is for $1,518,064.70 and has an ultimate completion date of July 24, 2028. The contract is for a "Small Dispensers Assessment and Business Process Improvement (BPI) to Establish a Quality Management System (QMS)." Caitta Inc. is a strategic federal...
- This is a firm fixed price contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Caitta Inc., an SBA certified 8(a) economically disadvantaged woman-owned small business. The contract is for the FDA's Center for Drug Evaluation and Research (CDER) Office of Compliance (OC) Compounding Program Business Process Improvement (BPI) and Quality Management System, with a completion date of August 15, 2024 and a potential value of $881,893.55. Caitta...
- This is a $190,800 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The contract is for knowledge management services. Caitta Inc. specializes in providing scientific, technical, and administrative services to federal health and research agencies, with expertise in supplying sophisticated scientific and...
- This firm-fixed-price delivery order contract was awarded to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB), by the Food and Drug Administration (FDA) for regulatory health project management services. The contract has a ceiling value of $372,662.98 and an ultimate completion date of July 3, 2021. Caitta Inc. is a key supplier to federal agencies like the Department of Health and Human Services (HHS), FDA, National Institutes of Health (NIH), and...
- This is a $238,950.95 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The contract is for RESEARCH SUPPORT FOR OSIS, with an ultimate completion date of September 27, 2016. Caitta Inc. has a diverse portfolio of federal contracts, including a $2 million GSA Federal Supply Schedule contract and a $999,000 multiple-award contract with the...
- The Department of Health and Human Services Food and Drug Administration awarded a $217,346.52 firm fixed price purchase order to Caitta Inc., an SBA certified 8(a) economically disadvantaged woman-owned small business. The award is for contractor support services, with a performance period ending on May 3, 2023. Caitta has a history of providing scientific, technical, and administrative services to HHS and its agencies, including the FDA, NIH, and NIST, through both competitive awards and...
- The Department of Health and Human Services Food and Drug Administration awarded a $264,472.08 firm fixed price delivery order contract to Caitta Inc. for benefit risk and quality assessment services. Caitta is an SBA-certified economically disadvantaged woman-owned small business that holds multiple vehicles to provide scientific, technical, and advisory services to federal health agencies. This includes a General Services Administration Federal Supply Schedule contract worth up to $2 million...
- This is a $266,000.00 Firm Fixed Price Purchase Order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Caitta Inc., an SBA-certified Economically Disadvantaged Women-Owned Small Business (EDWOSB) and 8(a) program participant. The contract is for a "Precedent Based Approach to Support Decision-Making Oncology", and was awarded as an 8(a) Sole Source contract. Caitta Inc. is a federal contractor that specializes in providing scientific, technical, and...
- This is a delivery order awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB), for temporary administrative staffing services to support the FDA's Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality (OPQ). The contract has a firm fixed price ceiling value of $23,870.00 and a period of performance through October 13, 2024. Caitta Inc. is the prime contractor and there are no...
This is a $149,470.00 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The contract is not set aside. The purpose of this effort is to integrate compliance within an existing quality management system (QMS) for regulating pharmaceutical quality. The contract does not involve information technology/systems development. Caitta Inc. has a significant Federal Supply Schedule contract with the General Services Administration (GSA) and has delivered advanced scientific instrumentation, analytical equipment, and professional support services to various federal civilian agencies. This contract award further demonstrates Caitta Inc.'s strategic positioning in the federal contracting ecosystem and its ability to provide specialized scientific equipment and services to support the FDA's public health and regulatory oversight missions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $149.5k | 9/11/23 |